These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

661 related articles for article (PubMed ID: 30903363)

  • 41. Metformin potentiates the effect of arsenic trioxide suppressing intrahepatic cholangiocarcinoma: roles of p38 MAPK, ERK3, and mTORC1.
    Ling S; Xie H; Yang F; Shan Q; Dai H; Zhuo J; Wei X; Song P; Zhou L; Xu X; Zheng S
    J Hematol Oncol; 2017 Feb; 10(1):59. PubMed ID: 28241849
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [New perspectives for metformin in cancer therapy].
    Loubière C; Dirat B; Tanti JF; Bost F
    Ann Endocrinol (Paris); 2013 May; 74(2):130-6. PubMed ID: 23587351
    [TBL] [Abstract][Full Text] [Related]  

  • 43. AMPK Activation by Metformin Promotes Survival of Dormant ER
    Hampsch RA; Wells JD; Traphagen NA; McCleery CF; Fields JL; Shee K; Dillon LM; Pooler DB; Lewis LD; Demidenko E; Huang YH; Marotti JD; Goen AE; Kinlaw WB; Miller TW
    Clin Cancer Res; 2020 Jul; 26(14):3707-3719. PubMed ID: 32321715
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Metabolomic fingerprint reveals that metformin impairs one-carbon metabolism in a manner similar to the antifolate class of chemotherapy drugs.
    Corominas-Faja B; Quirantes-Piné R; Oliveras-Ferraros C; Vazquez-Martin A; Cufí S; Martin-Castillo B; Micol V; Joven J; Segura-Carretero A; Menendez JA
    Aging (Albany NY); 2012 Jul; 4(7):480-98. PubMed ID: 22837425
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Metformin amplifies chemotherapy-induced AMPK activation and antitumoral growth.
    Rocha GZ; Dias MM; Ropelle ER; Osório-Costa F; Rossato FA; Vercesi AE; Saad MJ; Carvalheira JB
    Clin Cancer Res; 2011 Jun; 17(12):3993-4005. PubMed ID: 21543517
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Activation of AMP-activated protein kinase by metformin protects human coronary artery endothelial cells against diabetic lipoapoptosis.
    Eriksson L; Nyström T
    Cardiovasc Diabetol; 2014 Nov; 13():152. PubMed ID: 25391818
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Metformin in cancer.
    Mallik R; Chowdhury TA
    Diabetes Res Clin Pract; 2018 Sep; 143():409-419. PubMed ID: 29807101
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Metformin for lung cancer prevention and improved survival: a novel approach.
    Roos JF; Qudsi M; Samara A; Rahim MM; Al-Bayedh SA; Ahmed H
    Eur J Cancer Prev; 2019 Jul; 28(4):311-315. PubMed ID: 29481337
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Caffeic Acid Targets AMPK Signaling and Regulates Tricarboxylic Acid Cycle Anaplerosis while Metformin Downregulates HIF-1α-Induced Glycolytic Enzymes in Human Cervical Squamous Cell Carcinoma Lines.
    Tyszka-Czochara M; Bukowska-Strakova K; Kocemba-Pilarczyk KA; Majka M
    Nutrients; 2018 Jun; 10(7):. PubMed ID: 29958416
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Metformin - a Future Therapy for Neurodegenerative Diseases : Theme: Drug Discovery, Development and Delivery in Alzheimer's Disease Guest Editor: Davide Brambilla.
    Markowicz-Piasecka M; Sikora J; Szydłowska A; Skupień A; Mikiciuk-Olasik E; Huttunen KM
    Pharm Res; 2017 Dec; 34(12):2614-2627. PubMed ID: 28589443
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pharmacologic mechanisms underlying antidiabetic drug metformin's chemopreventive effect against colorectal cancer.
    Jaromy M; Miller JD
    Eur J Pharmacol; 2021 Apr; 897():173956. PubMed ID: 33617821
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Metformin and Its Immune-Mediated Effects in Various Diseases.
    Nojima I; Wada J
    Int J Mol Sci; 2023 Jan; 24(1):. PubMed ID: 36614197
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Metformin induces renal medullary interstitial cell apoptosis in type 2 diabetic mice.
    Zheng S; Liu J; Han Q; Huang S; Su W; Fu J; Jia X; Du S; Zhou Y; Zhang X; Guan Y
    J Diabetes; 2014 Mar; 6(2):132-46. PubMed ID: 24405721
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Metformin mediated reversal of epithelial to mesenchymal transition is triggered by epigenetic changes in E-cadherin promoter.
    Banerjee P; Surendran H; Chowdhury DR; Prabhakar K; Pal R
    J Mol Med (Berl); 2016 Dec; 94(12):1397-1409. PubMed ID: 27534967
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Metformin--mode of action and clinical implications for diabetes and cancer.
    Pernicova I; Korbonits M
    Nat Rev Endocrinol; 2014 Mar; 10(3):143-56. PubMed ID: 24393785
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Metformin: Insights into its anticancer potential with special reference to AMPK dependent and independent pathways.
    Ikhlas S; Ahmad M
    Life Sci; 2017 Sep; 185():53-62. PubMed ID: 28755883
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Metformin and AMPK: an old drug and a new enzyme in the context of metabolic syndrome].
    Santomauro Júnior AC; Ugolini MR; Santomauro AT; Souto RP
    Arq Bras Endocrinol Metabol; 2008 Feb; 52(1):120-5. PubMed ID: 18345405
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Metformin in selected malignancies in women.
    Markowska A; Stanislawiak-Rudowicz J; Kasprzak T; Markowska J; Szarszewska M
    Ginekol Pol; 2022; 93(5):416-421. PubMed ID: 35072253
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Activation of AMPK is neuroprotective in the oxidative stress by advanced glycosylation end products in human neural stem cells.
    Lin CH; Cheng YC; Nicol CJ; Lin KH; Yen CH; Chiang MC
    Exp Cell Res; 2017 Oct; 359(2):367-373. PubMed ID: 28821394
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Does use of metformin protect against cancer in Type 2 diabetes mellitus?
    Bo S; Benso A; Durazzo M; Ghigo E
    J Endocrinol Invest; 2012 Feb; 35(2):231-5. PubMed ID: 22490993
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.